Literature DB >> 11087562

Structure-function studies on the new growth hormone-releasing peptide, ghrelin: minimal sequence of ghrelin necessary for activation of growth hormone secretagogue receptor 1a.

M A Bednarek1, S D Feighner, S S Pong, K K McKee, D L Hreniuk, M V Silva, V A Warren, A D Howard, L H Van Der Ploeg, J V Heck.   

Abstract

The recently discovered growth hormone secretagogue, ghrelin, is a potent agonist at the human growth hormone secretagogue receptor 1a (hGHSR1a). To elucidate structural features of this peptide necessary for efficient binding to and activation of the receptor, several analogues of ghrelin with various aliphatic or aromatic groups in the side chain of residue 3, and several short peptides derived from ghrelin, were prepared and tested in a binding assay and in an assay measuring intracellular calcium elevation in HEK-293 cells expressing hGHSR1a. Bulky hydrophobic groups in the side chain of residue 3 turned out to be essential for maximum agonist activity. Also, short peptides encompassing the first 4 or 5 residues of ghrelin were found to functionally activate hGHSR1a about as efficiently as the full-length ghrelin. Thus the entire sequence of ghrelin is not necessary for activity: the Gly-Ser-Ser(n-octanoyl)-Phe segment appears to constitute the "active core" required for agonist potency at hGHSR1a.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11087562     DOI: 10.1021/jm0001727

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  113 in total

Review 1.  Ghrelin: the link connecting growth with metabolism and energy homeostasis.

Authors:  Felipe F Casanueva; Carlos Dieguez
Journal:  Rev Endocr Metab Disord       Date:  2002-12       Impact factor: 6.514

Review 2.  Electrophysiological analysis of circuits controlling energy homeostasis.

Authors:  Masoud Ghamari-Langroudi
Journal:  Mol Neurobiol       Date:  2012-02-14       Impact factor: 5.590

3.  Ghrelin and cortistatin in lung cancer: expression of peptides and related receptors in human primary tumors and in vitro effect on the H345 small cell carcinoma cell line.

Authors:  P Cassoni; E Allia; T Marrocco; C Ghè; E Ghigo; G Muccioli; M Papotti
Journal:  J Endocrinol Invest       Date:  2006-10       Impact factor: 4.256

Review 4.  Ghrelin: a new player in the control of gastrointestinal functions.

Authors:  T L Peeters
Journal:  Gut       Date:  2005-11       Impact factor: 23.059

5.  Aqueous humour levels of ghrelin in exfoliation syndrome and exfoliation glaucoma patients.

Authors:  Ayşe Vural Ozeç; Ayhan Dursun; Mustafa Ilker Toker; Yüksel Demirci; Aysen Topalkara; Haydar Erdoğan; Mustafa Kemal Arıcı; Taner Ersalcan
Journal:  Jpn J Ophthalmol       Date:  2014-05-08       Impact factor: 2.447

6.  Analysis of brain nuclei accessible to ghrelin present in the cerebrospinal fluid.

Authors:  A Cabral; G Fernandez; M Perello
Journal:  Neuroscience       Date:  2013-09-13       Impact factor: 3.590

7.  Serum leptin and ghrelin concentrations of maternal serum, arterial and venous cord blood in healthy and preeclamptic pregnant women.

Authors:  S Aydin; S P Guzel; S Kumru; Suna Aydin; O Akin; E Kavak; I Sahin; M Bozkurt; I Halifeoglu
Journal:  J Physiol Biochem       Date:  2008-03       Impact factor: 4.158

8.  Human ghrelin ameliorates organ injury and improves survival after radiation injury combined with severe sepsis.

Authors:  Kavin G Shah; Rongqian Wu; Asha Jacob; Steven A Blau; Youxin Ji; Weifeng Dong; Corrado P Marini; Thanjavur S Ravikumar; Gene F Coppa; Ping Wang
Journal:  Mol Med       Date:  2009-09-18       Impact factor: 6.354

Review 9.  Ghrelin forms in the modulation of energy balance and metabolism.

Authors:  Gianluca Gortan Cappellari; Rocco Barazzoni
Journal:  Eat Weight Disord       Date:  2018-10-24       Impact factor: 4.652

10.  Inhibition of ghrelin action in vitro and in vivo by an RNA-Spiegelmer.

Authors:  Steffen Helmling; Christian Maasch; Dirk Eulberg; Klaus Buchner; Werner Schröder; Christian Lange; Stefan Vonhoff; Britta Wlotzka; Matthias H Tschöp; Stefan Rosewicz; Sven Klussmann
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-25       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.